Medication info
Alendroplus D Tablet

Alendroplus D Tablet

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
White to grayish-white oblong tablet
Packaging
4 tablets [(4 tablets/PTP) × 1]
Approval status
Active

MFDS item code 201309508 · Approved 2013.09.30 · Insurance code 645905530

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Discontinuation of treatment should be considered after 3~5 years in patients at low risk of fracture. Patients who discontinue treatment should have their fracture risk reassessed regularly. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce absorption of alendronate in the body and decrease its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medication reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the drug and until after your first food intake. Do not take this drug at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This drug, taken once weekly, provides a week's supply of vitamin D at daily amounts of 400 IU and 800 IU. If a patient taking 1 tablet of this drug forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and thereafter take it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years of age or older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this drug is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.
Child dose
Children and adolescents (under 18 years of age): The safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

Osteoporosis is a disease that causes bones to weaken and increases the risk of fractures. This medication is used for the treatment of osteoporosis in postmenopausal women and men. It improves bone density, enhances bone health, and reduces the risk of fractures. Therefore, it greatly helps in strengthening bones and preventing complications caused by osteoporosis.

How to take

Adult dose

Take 1 tablet (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Discontinuation of treatment should be considered after 3~5 years in patients at low risk of fracture. Patients who discontinue treatment should have their fracture risk reassessed regularly. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce absorption of alendronate in the body and decrease its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medication reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the drug and until after your first food intake. Do not take this drug at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This drug, taken once weekly, provides a week's supply of vitamin D at daily amounts of 400 IU and 800 IU. If a patient taking 1 tablet of this drug forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and thereafter take it regularly once weekly. Do not take 2 tablets on the same day. Administration to elderly patients (65 years of age or older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 35∼60 mL/min). However, use of this drug is not recommended in patients with severe renal impairment (creatinine clearance below 35 mL/min), because there is insufficient clinical experience.

Child dose

Children and adolescents (under 18 years of age): The safety and efficacy in children and adolescents have not been established.

Precautions

This medication may irritate the stomach, potentially leading to issues such as esophagitis or esophageal ulcers. After taking it, do not lie down, and take it with a sufficient amount of water to reduce the risk of esophageal irritation. If you experience any abnormal symptoms such as dysphagia or heartburn, stop taking the medication and consult a doctor. Patients with esophageal clearance disorders or who cannot sit or stand for more than 30 minutes should not take this medication. Patients with low calcium levels or those allergic to the ingredients of this medication should also avoid it. This drug is used for treating osteoporosis, and side effects such as abdominal pain, indigestion, constipation, diarrhea, muscle pain, and headaches may occur in some patients. Care is required, especially as gastrointestinal-related side effects may arise. If there is a vitamin D deficiency, additional supplementation may be necessary, and weight-bearing exercise and a healthy lifestyle are also important. Drug interactions may occur when used in combination with other medications, so calcium supplements or antacids should be taken at least 30 minutes apart from this medication. Pregnant or nursing individuals should consult a doctor to determine whether to take this medication, and it is not to be used in children. It is not recommended for patients with severely impaired kidney function. In case of overdose, gastrointestinal irritation and hypocalcemia may occur, hence caution is essential; emesis should be avoided, and immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to another container.

Side effects

Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, taste disturbances, rash, erythema, anastomotic ulcer, urticaria, angiopathy, myalgia, malaise, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oral-pharyngeal ulcer, gastric ulcer, duodenal ulcer, local jaw necrosis, joint swelling, low-energy fractures of the femoral head and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It should be kept at room temperature, maintaining a temperature between 1°C and 30°C, and away from direct light.

Appearance and packaging

Appearance

White to grayish-white oblong tablet

Package unit

4 tablets [(4 tablets/PTP) × 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.